Syndax Pharmaceuticals Inc
0.23 (1.08%)
Company Name Stock Ticker Symbol Market Type
Syndax Pharmaceuticals Inc SNDX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.23 1.08% 21.55 19:58:43
Open Price Low Price High Price Close Price Prev Close
21.50 21.36 21.7254 21.55 21.32
more quote information »

Recent News

Date Time Source Heading
3/29/20232:01IHNWFeatured1606 Corp Announces Pivotal Distribution Deal With a Premier CBD Distributor
3/15/202316:05PRNUSSyndax Pharmaceuticals Announces Two Publications in Nature..
3/14/202316:43EDGARStatement of Changes in Beneficial Ownership (4)
3/06/202316:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
2/28/202316:20EDGARSecurities Registration: Employee Benefit Plan (s-8)
2/28/202316:13EDGARAnnual Report (10-k)
2/28/202316:07EDGARCurrent Report Filing (8-k)
2/28/202316:03PRNUSSyndax Pharmaceuticals Reports Fourth Quarter and Full Year..
2/21/202307:00PRNUSSyndax to Announce Fourth Quarter and Year-end 2022..
2/14/202317:12EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202315:48EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202307:00PRNUSSyndax Announces Participation at Upcoming Investor..
2/08/202316:50EDGARStatement of Changes in Beneficial Ownership (4)
2/08/202316:33EDGARCurrent Report Filing (8-k)
2/06/202314:47EDGARAmended Statement of Ownership (sc 13g/a)
2/03/202317:02EDGARStatement of Changes in Beneficial Ownership (4)
2/03/202316:59EDGARStatement of Changes in Beneficial Ownership (4)
2/03/202316:59EDGARStatement of Changes in Beneficial Ownership (4)
2/03/202316:58EDGARStatement of Changes in Beneficial Ownership (4)
2/03/202316:53EDGARStatement of Changes in Beneficial Ownership (4)
2/03/202316:52EDGARStatement of Changes in Beneficial Ownership (4)
1/13/202316:45EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202307:00PRNUSSyndax Announces Presentation at 41st Annual J.P. Morgan..
12/14/202216:32EDGARCurrent Report Filing (8-k)
12/14/202216:05PRNUSSyndax Announces Closing of Public Offering of Common Stock..
12/12/202211:35TRMNGoldman Sachs Sticks to Their Buy Rating for Syndax..
12/10/202217:00PRNUSSyndax Announces Positive Updated Data from Phase 1 Portion..
12/08/202217:06PRNUSSyndax Pharmaceuticals Reports Inducement Grant Under NASDAQ..
12/07/202216:05EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
12/07/202200:10TRMNAnalysts’ Top Healthcare Picks: Syndax Pharmaceuticals..
12/06/202221:38PRNUSSyndax Announces Pricing of $150 Million Public Offering of..
12/06/202217:08EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
12/06/202216:30PRNUSSyndax Announces Proposed $150 million Public Offering of..
12/05/202216:42EDGARStatement of Changes in Beneficial Ownership (4)
12/05/202216:37EDGARInitial Statement of Beneficial Ownership (3)
12/05/202211:15TRMNH.C. Wainwright Remains a Buy on Syndax Pharmaceuticals..
12/05/202208:12DJNSyndax Gets FDA Breakthrough Designation for Revumenib in..
12/05/202207:15PRNUSSyndax Announces U.S. FDA Breakthrough Therapy Designation..
12/05/202207:09EDGARCurrent Report Filing (8-k)
12/05/202207:00PRNUSSyndax Pharmaceuticals and Incyte Announce Axatilimab Phase..
12/02/202217:02EDGARStatement of Changes in Beneficial Ownership (4)
12/02/202207:00PRNUSSyndax Pharmaceuticals Announces Appointment of Steve Sabus..
11/21/202207:00PRNUSSyndax Announces Participation at Evercore ISI Annual..
11/04/202210:10TRMNAnalysts Are Bullish on Top Healthcare Stocks: Matinas..
11/03/202216:13EDGARQuarterly Report (10-q)
11/03/202216:05EDGARCurrent Report Filing (8-k)
11/03/202216:05PRNUSSyndax Pharmaceuticals Reports Third Quarter 2022 Financial..
11/03/202209:00PRNUSSyndax Announces Positive Updates to Clinical Activity and..
10/27/202207:00PRNUSSyndax to Announce Third Quarter 2022 Financial Results and..
10/07/202216:06EDGARStatement of Changes in Beneficial Ownership (4)
10/04/202217:50EDGARStatement of Changes in Beneficial Ownership (4)